AVIARA PHARMACEUTICALS, INC.
Biotech · Private
Dual α4β1 and α4β7 integrin antagonist therapeutic for inflammatory bowel disease
- Grants
- $2.3M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Selective targeting of high affinity alpha4 integrins as a safe treatment strategy for IBD | $296,724 | |
| Federal grant | Department of Health and Human Services · Phase II · Selective targeting of high affinity alpha4 integrins as a safe treatment strategy for IBD | $1,036,641 | |
| Federal grant | Department of Health and Human Services · Phase II · Selective targeting of high affinity alpha4 integrins as a safe treatment strategy for IBD | $959,682 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2043 | ALGOMEDIX, INC. | — | — |
| 2044 | Scale-Up International Inc. | — | $84K |
| 2045 | Tango Biosciences Inc. | — | — |
| 2046 | AVIARA PHARMACEUTICALS, INC. | — | — |
| 2047 | BLR BIO, LLC | — | — |
| 2048 | KEYBIOME INC | — | — |
| 2049 | Seven Bridges Capital LLC | — | $1.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Propionic Acid Derivatives And Methods Of Use Thereofapplication
- Propionic Acid Derivatives And Methods Of Use Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.